Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Martinez-Ordoñez A, Cid-Diaz T, Duran A, Han Q, Moscat J, Diaz-Meco MT. Whole-mount staining of mouse colorectal cancer organoids and fibroblast-organoid co-cultures. STAR Protoc. 2023;4(2):102243.

Petersen J, Du W, Adkisson C, Gravekamp C, Oktay MH, Condeelis J, et al. Stabilized Window for Intravital Imaging of the Murine Pancreas. J Vis Exp. 2023;(200).

Chadburn A. Post-transplant lymphoproliferative disorders (PTLD) in adolescents and young adults: A category in need of definition. Semin Diagn Pathol. 2023;40(6):401-407.

Zeng X, Yang M, Ye T, Feng J, Xu X, Yang H, et al. Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)-NF-кB axis. Free Radic Biol Med. 2023;202:46-61.

Saoud C, Illei PB, Siddiqui MT, Ali SZ. Cytopathology of rare gastric mesenchymal neoplasms: A series of 25 cases and review of literature. Cytopathology. 2023;34(1):15-27.

Xie Q, Schenck EJ, Yang HS, Chen Y, Peng Y, Wang F. Faithful AI in Medicine: A Systematic Review with Large Language Models and Beyond. medRxiv. 2023.

Saoud C, Wakely PE, Pantanowitz L, Siddiqui MT, Ali SZ. Chondroblastoma: Cytomorphologic Analysis of 10 Cases with Review of the Literature. Acta Cytol. 2023;67(4):413-424.

Usui J, Salvatore SP, Yamagata K, Seshan SV. Clinicopathologic Spectrum of Renal Lesions Following Anti-TNF- α Inhibitor Therapy: A Single Center Experience. Kidney360. 2023;4(3):363-373.

González-Muñoz T, Di Giannatale A, García-Silva S, Santos V, Sánchez-Redondo S, Savini C, et al. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Clin Cancer Res. 2023;29(18):3744-3758.

Ma C, Zhou Y, Fanelli GN, Stopsack KH, Fiorentino M, Zadra G, et al. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Mol Cancer Res. 2023;21(3):253-260.